Abstract
Aim:
To compare the pharmacokinetic parameters of cefuroxime lysine, a new second-generation of cephalosporin antibiotics, after intravenous (IV), intraperitoneal (IP), or intramuscular (IM) administration.
Methods:
Twelve male and 12 virgin female Sprague-Dawley rats, weighing from 200 to 250 g, were divided into three groups (n=4 for each gender in each group). The rats were administered a single dose (67.5 mg/kg) of cefuroxime lysine via IV bolus or IP or IM injection. Blood samples were collected and analyzed with a validated UFLC-MS/MS method. The concentration-time data were then calculated by compartmental and non-compartmental pharmacokinetic methods using DAS software.
Results:
After IV, IP or IM administration, the plasma cefuroxime lysine disposition was best described by a tri-compartmental, bi-compartmental or mono-compartmental open model, respectively, with first-order elimination. The plasma concentration profiles were similar through the 3 administration routes. The distribution process was rapid after IV administration [t1/2(d), 0.10±0.11 h vs 1.36±0.65 and 1.25±1.01 h]. The AUMC0–∞ is markedly larger, and mean residence time (MRT) is greatly longer after IP administration than that in IV, or IM routes (AUMC0–∞: 55.33±20.34 vs 16.84±4.85 and 36.17±13.24 mg·h2/L; MRT: 0.93±0.10 h vs 0.37±0.07 h and 0.65±0.05 h). The Cmax after IM injection was significantly higher than that in IP injection (73.51±12.46 vs 49.09±7.06 mg/L). The AUC0–∞ in male rats were significantly higher than that in female rats after IM administration (66.38±16.5 vs 44.23±6.37 mg·h/L). There was no significantly sex-related difference in other pharmacokinetic parameters of cefuroxime lysine between male and female rats.
Conclusion:
Cefuroxime lysine shows quick absorption after IV injection, a long retension after IP injection, and a high Cmax after IM injection. After IM administration the AUC0–∞ in male rats was significantly larger than that in female rats.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Vazquez JC, Abalos E . Treatments for symptomatic urinary tract infections during pregnancy. Cochrane Database Syst Rev 2011; (1): CD002256.
Bae S, Lee J, Lee J, Kim E, Lee S, Yu J, et al. Antimicrobial resistance in Haemophilus influenzae respiratory tract isolates in Korea: results of a nationwide acute respiratory infections surveillance. Antimicrob Agents Chemother 2010; 54: 65–71.
Bischoff M, Beck A, Frei P, Bischoff G . Pharmacokinetics of cefuroxime in traumatic wound secretion and antibacterial activity under vacuum therapy. J Chemother 2010; 22: 92–7.
Asiri YA, AI-Hadiya BM, Kadi AA, Al-Khamis KI, Mowafy HA, El-Sayed YM . Comparative bioavailability study of cefuroxime axetil (equivalent to 500 mg cefuroxime/table) tablets (Zednad® versus Zinnat®) in healthy male volunteers. Int J Clin Pharmacol Ther 2011; 49: 571–6.
Ruiz-Carretero P, Merino-Sanjuán M, Nácher A, Casabó VG . Pharmacokinetic models for the saturable absorption of cefuroxime axetil and saturable elimination of cefuroxime. Eur J Pharm Sci 2004; 21: 217–23.
Abo El-sooud K, El-Banna HA, Hanafy MS, Goudah A . Pharmacokinetics and intramuscular bioavailability of cefuroxime sodium in goats. Res Vet Sci 2000; 69: 219–24.
Chaudhary RK, Srivastava AK, Rampal S . Modification of the pharmacokinetics and dosage of cefuroxime by endotoxin-induced fever in buffalo calves. Vet Res Commun 1999; 23: 361–8.
Zhao LS, Zhao YL, Li Q, Chen XH, Xiao F, He BS, et al. A fast, sensitive, and high throughput method for the determination of cefuroxime lysine in dog plasma by UPLC-MS/MS. Talanta 2012; 89: 84–90.
Viberg A, Sandström M, Jansson B . Determination of cefuroxime in human serum or plasma by liquid chromatography with electrospray tandem mass spectrometry. Rapid Commun Mass Spectrom 2004; 18: 707–10.
Zhao LS, Li Q, Yang W, He BS, Wei BB, Liu R, et al. Determination of cefuroxime in liver-injured rat plasma by ultra-fast liquid chromatography-tandem mass spectrometry via acidified protein precipitation. Chin J Chromatogr 2012; doi: 10.3724/SP.J.1123.2012.03001.
Yamaoka K, Nakagawa T, Uno T . Statistical moments in pharmacokientics. J Pharmacokinet Biopharm 1978; 6: 547–58.
Grasso S, Meinardi G, de Carneri I, Tamassia V . New in vitro model to study the effect of antibiotic concentration and rate of elimination on antibacterial activity. Antimicrob Agents Chemother 1978; 13: 570–6.
Murakawa T, Sakamoto H, Hirose T, Nishida M . New in vitro kinetic model for evaluting bactericidal efficacy of antibiotics. Antimicrob Agents Chemother 1980; 18: 377–81.
Gibaldi M, Perrier D . Pharmacokinetics, second ed. New York: Marcel Dekker Inc; 1982.
Chen ML, Chiou WL . Tissue metabolism and distribution of methotrexate in rabbits. Drug Metab Dispos 1982; 10: 706–7.
Dimitrova D, Moutafchieva R, Kanelov I, Dinev T, Lashev L . Pharmacokinetics of tobramycin in ducks and sex-related differences. Vet J 2009; 179: 462–4.
Powers J . Statistical analysis of pharmacokinetics data. J Vet Pharmacol Ther 1990; 13: 113–20.
Snedecor GW, Cochran WG . Statistical Methods, seventh ed. Ames (Iowa): Iowa State University Press; 1980. p 39–63.
Gower PE, Dash CH . The pharmacokinetics of cefuroxime after intravenous injection. Eur J Clin Pharmacol 1977; 12: 221–7.
Tsai TH, Cheng FC, Chen KC, Chen YF, Chen CF . Simultaneous measurement of cefuroxime in rat blood and brain by microdialysis and microbore liquid chromatography. Application to pharmacokinetics. J Chromatogr B 1999; 735: 25–31.
Viberg A, Lannergård A, Larsson A, Cars O, Karlsson MO, Sandström M . A population pharmacokinetic model for cefuroxime using cystatin C as a marker of renal function. Br J Clin Pharmacol 2006; 62: 297–303.
Knoderer CA, Saft SA, Walker SG, Rodefeld MD, Turrentine MW, Brown JW, et al. Cefuroxime pharmacokinetics in pediatric cardiovascular surgery patients undergoing cardiopulmonary bypass. J Cardiothorac Vasc Anesth 2011; 25: 425–30.
Haddad NS, Pedersoli WM, Ravis WR, Fazeli MH, Carson RL . Combined pharmacokinetics of gentamicin in pony mares after a single intravenous and intramuscular administration. Am J Vet Res 1985; 46: 2004–7.
Albarellos GA, Ambros LA, Landoni MF . Pharmacokinetics of ceftazidime after intravenous and intramuscular administration to domestic cats. Vet J 2008; 178: 238–43.
Sultana N, Arayne MS . In vitro activity of cefazoline and cefuroxime in presence of essential and trace elements. Pak J Pharm Sci 2002; 15: 41–50.
Toutain PL, Del Castillo JRE, Bousquet-Mélou A . The pharmacokinetic-pharmacodynamic approach to a rational dosage regimen for antibiotics. Res Vet Sci 2002; 73: 105–14.
McKellar QA, Sanchez Bruni SF, Jones DG . Pharmacokinetic/pharmacodynamic relationships of antimicrobial drugs used in veterinary medicine. J Vet Pharm Ther 2004; 27: 503–14.
Albarellos GA, Montoya L, Landoni MF . Pharmacokinetics of erythromycin after intravenous, intramuscular and oral administration to cats. Vet J 2011; 187: 129–32.
Acknowledgements
This study was supported by the National Key Scientific Project for New Drug Discovery and Development (No 2009 ZX09301-012). We wish to thank the excellent technical assistance of Dr Wei YANG and Bai-quan XIAO et al of Guangzhou Institute of Pharmaceutical Industry for their excellent work.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zhao, Ls., Yin, R., Wei, Bb. et al. Comparative pharmacokinetics of cefuroxime lysine after single intravenous, intraperitoneal, and intramuscular administration to rats. Acta Pharmacol Sin 33, 1348–1352 (2012). https://doi.org/10.1038/aps.2012.99
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/aps.2012.99
Keywords
This article is cited by
-
Dynamics of collagen oxidation and cross linking in regenerating and irreversibly infarcted myocardium
Nature Communications (2024)
-
Pharmacometrics: a quantitative tool of pharmacological research
Acta Pharmacologica Sinica (2012)
